QuantX

QuantX Biosciences is a computation-powered drug discovery company headquartered in Princeton, New Jersey, focused on developing oral small molecule therapeutics for immunology and oncology applications. The company leverages a proprietary computational platform that combines physics-based and statistical modeling with high-performance computing re... sources to accelerate the discovery and optimization of small molecule drug candidates. QuantX Biosciences operates as a preclinical-stage biotechnology company with a team of experienced drug discovery veterans dedicated to advancing breakthrough medicines. The company's research pipeline includes novel inhibitors targeting DNA polymerase theta for cancer treatment, interleukin-17 inhibitors for autoimmune and inflammatory diseases, and PARG inhibitors for oncology indications. QuantX Biosciences integrates advanced computational chemistry tools with medicinal chemistry design to identify and develop superior oral small molecule therapeutics that address unmet medical needs in immunology and oncology.Read More